To assess Notch1 and Notch2 activity, we used SNAP23 and BCAT2, two downstream targets of Notch1 and 2, respectively, that we identified by a microarray analysis of human melanoma cells in which each Notch receptor was inhibited by a specific shRNA (Fig. 2C, D). The gene discussed is SNAP23; the disease is melanoma.